المؤلفون: Kefeng Liu, Qiong Li, Xiaojing Lu, Xintong Fan, Yongjie Yang, Wei Xie, Jian Kang, Shusen Sun, Jie Zhao

المصدر: Pharmaceutical Biology, Vol 62, Iss 1, Pp 404-422 (2024)

مصطلحات موضوعية: Disease control rate, objective control rate, Karnofsky performance status, adverse reaction, efficacy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1388-0209; https://doaj.org/toc/1744-5116

URL الوصول: https://doaj.org/article/3491f1c4c4d048da9e15dc04fcfb864e

المؤلفون: Natale Quartuccio, Vincenzo Militano, Marco Pappalardo, Luca Filippi, Oreste Bagni, Antonino Maria Moreci, Salvatore Ialuna

المصدر: Current Oncology, Vol 31, Iss 11, Pp 6879-6890 (2024)

مصطلحات موضوعية: breast cancer, radioembolization, resin, glass, objective response rate, disease control rate, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1718-7729/31/11/508; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

URL الوصول: https://doaj.org/article/d7bcbc509f354925a3ae265928d1de4f

المؤلفون: Daolin Zeng, Chunlin Yu, Shiyao Chen, Long Zou, Junjun Chen, Linlong Xu

المصدر: World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-11 (2024)

مصطلحات موضوعية: Advanced liver cancer, Transarterial chemoembolization, Sorafenib, Disease control rate, Clinical efficacy, Targeted therapy, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1477-7819

URL الوصول: https://doaj.org/article/1997fdd9b00c4451a0b76782e628a8b5

المؤلفون: LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai

المصدر: Jichu yixue yu linchuang, Vol 44, Iss 2, Pp 247-251 (2024)

مصطلحات موضوعية: cinobufotalin, dp chemotherapy, non-small cell lung cancer, vascular endothelial growth factor, disease control rate, Medicine

وصف الملف: electronic resource

Relation: http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2024-44-2-247.pdf; https://doaj.org/toc/1001-6325

URL الوصول: https://doaj.org/article/eb1958f083bd441f8ea8fbf45d604ba2

المؤلفون: Ping Wang, Lei Xia

المصدر: BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)

مصطلحات موضوعية: RC48-ADC, HER2, Solid tumors, Disease control rate, Progression-free survival, Safety, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/c36fb32a3b064927a01aefebe357818b

المؤلفون: Gilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, Malgorzata Ulanska, Hugues Bourgeois, Montserrat Muñoz, Serafin Morales, Juan Bayo Calero, Laura Cortesi, Tamás Pintér, Markéta Palácová, Nelli Cherciu, Edgar Petru, Johannes Ettl, Cécilia de Almeida, Gustavo Villanova, Romain Raymond, Christine Ta Thanh Minh, Ana Rodrigues, Marina E. Cazzaniga

المصدر: Breast, Vol 74, Iss , Pp 103681- (2024)

مصطلحات موضوعية: Administration, Metronomic, Oral, Chemotherapy, Disease control rate, HR+/HER2-advanced breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S0960977624000122; https://doaj.org/toc/1532-3080

URL الوصول: https://doaj.org/article/0b574b9f1cb64611a2fd0d40a3bafcde

المؤلفون: Machiko Kai, Hayato Hikita, Maesaka Kazuki, Yuki Tahata, Kazuma Shinkai, Akira Doi, Kazuyoshi Ohkawa, Masanori Miyazaki, Hisashi Ishida, Kengo Matsumoto, Yasutoshi Nozaki, Takayuki Yakushijin, Ryotaro Sakamori, Akira Kaneko, Sadaharu Iio, Takatoshi Nawa, Naruyasu Kakita, Naoki Morishita, Naoki Hiramatsu, Takeo Usui, Kazuho Imanaka, Yoshinori Doi, Mitsuru Sakakibara, Yuichi Yoshida, Tsugiko Oze, Takahiro Kodama, Tomohide Tatsumi, Tetsuo Takehara

مصطلحات موضوعية: Ecology, Immunology, Cancer, Science Policy, Biological Sciences not elsewhere classified, unresectable hepatocellular carcinoma, severe adverse events, objective response rate, independent risk factors, grade &# 8805, disease control rate, clinical factors associated, atezolizumab plus bevacizumab, absent macrovascular invasion, 9 months vs, 6 %, respectively, 3 months vs, 0 months vs, shortened overall survival, median overall survival, 8 months ), 7 months ), overall survival, 7 months, free survival, 6 ), shortened progression, median progression, %22">xlink ">

Relation: https://figshare.com/articles/journal_contribution/The_frequency_of_severe_AEs_/24928211

الاتاحة: https://doi.org/10.1371/journal.pone.0294590.s003
https://figshare.com/articles/journal_contribution/The_frequency_of_severe_AEs_/24928211

المؤلفون: Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang

مصطلحات موضوعية: Endocrinology, Oncology and Carcinogenesis not elsewhere classified, Aged Health Care, Health and Community Services, prognostic factors, advanced intrahepatic cholangiocarcinoma, therapy, biliary tract cancer, progression-free survival, disease control rate, tumor progression, overall survival

Relation: https://figshare.com/articles/journal_contribution/sj-docx-1-ict-10_1177_15347354231223967_Supplemental_material_for_Pharmacokinetic_Analysis_of_Prognostic_Factors_in_Patients_With_Advanced-Stage_Intrahepatic_Cholangiocarcinoma_Following_the_Administration_of_Capsule_Formulation_of_the_Stan/25122945

الاتاحة: https://doi.org/10.25384/sage.25122945.v1
https://figshare.com/articles/journal_contribution/sj-docx-1-ict-10_1177_15347354231223967_Supplemental_material_for_Pharmacokinetic_Analysis_of_Prognostic_Factors_in_Patients_With_Advanced-Stage_Intrahepatic_Cholangiocarcinoma_Following_the_Administration_of_Capsule_Formulation_of_the_Stan/25122945

المؤلفون: Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse

مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Biological Sciences not elsewhere classified, unresectable hepatocellular carcinoma, prospective cohort study, objective response rate, marketing surveillance study, disease control rate, better performance status, better overall conditions, better modified albumin, adverse drug reactions, relative dose intensity, physician &# 8217, na &# 239, treatment group often, median treatment duration, term lenvatinib treatment, longer treatment tended, longer treatment period, lenvatinib dose modifications, initial 177 days, hoc analysis aimed, e ., rdi, two treatment groups, treatment (& lt

Relation: https://figshare.com/articles/journal_contribution/Kaplan-Meier_curves_for_a_treatment_duration_and_b_overall_survival_according_to_treatment_response_CR_or_PR_vs_SD_or_PD_/25372142

الاتاحة: https://doi.org/10.1371/journal.pone.0298420.s003

المؤلفون: Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse

مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Biological Sciences not elsewhere classified, unresectable hepatocellular carcinoma, prospective cohort study, objective response rate, marketing surveillance study, disease control rate, better performance status, better overall conditions, better modified albumin, adverse drug reactions, relative dose intensity, physician &# 8217, na &# 239, treatment group often, median treatment duration, term lenvatinib treatment, longer treatment tended, longer treatment period, lenvatinib dose modifications, initial 177 days, hoc analysis aimed, e ., rdi, two treatment groups, treatment (& lt

Relation: https://figshare.com/articles/journal_contribution/The_occurrence_of_ADRs_sup_a_sup_that_lead_to_treatment_discontinuation_n_703_/25372136

الاتاحة: https://doi.org/10.1371/journal.pone.0298420.s001

المؤلفون: Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse

مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Biological Sciences not elsewhere classified, unresectable hepatocellular carcinoma, prospective cohort study, objective response rate, marketing surveillance study, disease control rate, better performance status, better overall conditions, better modified albumin, adverse drug reactions, relative dose intensity, physician &# 8217, na &# 239, treatment group often, median treatment duration, term lenvatinib treatment, longer treatment tended, longer treatment period, lenvatinib dose modifications, initial 177 days, hoc analysis aimed, e ., rdi, two treatment groups, treatment (& lt

Relation: https://figshare.com/articles/journal_contribution/Tumor_response_by_with_or_without_dose_modification_during_the_initial_eight_weeks_of_treatment_in_patients_with_8_weeks_of_treatment_n_423_sup_a_sup_/25372139

الاتاحة: https://doi.org/10.1371/journal.pone.0298420.s002

المؤلفون: Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse

مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Biological Sciences not elsewhere classified, unresectable hepatocellular carcinoma, prospective cohort study, objective response rate, marketing surveillance study, disease control rate, better performance status, better overall conditions, better modified albumin, adverse drug reactions, relative dose intensity, physician &# 8217, na &# 239, treatment group often, median treatment duration, term lenvatinib treatment, longer treatment tended, longer treatment period, lenvatinib dose modifications, initial 177 days, hoc analysis aimed, e ., rdi, two treatment groups, treatment (& lt

Relation: https://figshare.com/articles/journal_contribution/The_transition_of_mean_RDIs_per_two_weeks_in_the_overall_study_population_n_703_/25372145

الاتاحة: https://doi.org/10.1371/journal.pone.0298420.s004

المؤلفون: Rongxing Liu, Qiurong Shen, Hongjun Lu

المصدر: Journal of Cardiothoracic Surgery, Vol 17, Iss 1, Pp 1-12 (2022)

مصطلحات موضوعية: Chemotherapy, Thermal ablation, Lung malignancy, Objective response rate, Disease control rate, Progression-free survival, Surgery, RD1-811, Anesthesiology, RD78.3-87.3

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1749-8090

URL الوصول: https://doaj.org/article/297665487fa743ac96195288836a5d40

المؤلفون: Guocan Yu, Yanqin Shen, Liangliang Chen, Xudong Xu, Jun Yang

المصدر: Frontiers in Medicine, Vol 10 (2023)

مصطلحات موضوعية: NSCLC, DEB-BACE, BACE, objective response rate, disease control rate, PFS, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2023.1201468/full; https://doaj.org/toc/2296-858X

URL الوصول: https://doaj.org/article/865de4c92d444fe7b0f4612b2f6b2643

المؤلفون: Meiling Sun, Huaijun Ji, Ning Xu, Peng Jiang, Tao Qu, Yu Li

المصدر: BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)

مصطلحات موضوعية: Immune checkpoint inhibitors (ICIs), PD-L1 inhibitor, NSCLC, Objective response rate, Disease control rate, Median progression-free survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/9ce9105bbbab48fa8020760f3fd37679

المؤلفون: Yi, Min, He, Ting, Wang, Kaijin, Wei, Yonggang

المصدر: Clinics; v. 78 (2023); 100152 ; Clinics; Vol. 78 (2023); 100152 ; 1980-5322 ; 1807-5932

مصطلحات موضوعية: NSCLC, Gefitinib, Chemotherapy, Objective response rate, Disease control rate, Progression-free survival, Overall survival, Complication

وصف الملف: application/pdf

Relation: https://www.revistas.usp.br/clinics/article/view/214052/196283; https://www.revistas.usp.br/clinics/article/view/214052

الاتاحة: https://www.revistas.usp.br/clinics/article/view/214052

المؤلفون: Yaru Guo, Yuanyuan Chen, Yingnan Zhang, Mengjun Xu, Wenwen Guo, Jingya Zhang, Gaolei Ma, Chen Liu, Juan Yang, Xiaojin Wu

مصطلحات موضوعية: Medicine, Biotechnology, Immunology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, transcatheter arterial chemoembolization, recombinant human adenovirus, 67 &# 8211, 65 &# 8211, 28 &# 8211, 13 &# 8211, 09 &# 8211, 02 &# 8211, disease control rate, patients &# 8217, involved 1045 patients, tace markedly improved, meta analysis indicated, clinical curative effects, analysis , 95 &# 8211, 62 &# 8211, 001 ), better survival benefit, +rad%22">xlink "> rad, %22">xlink ">, survival rate

Time: 1

Relation: https://figshare.com/articles/journal_contribution/Pubmed_literature_search_strategies_/24889870

الاتاحة: https://doi.org/10.1371/journal.pone.0295323.s001
https://figshare.com/articles/journal_contribution/Pubmed_literature_search_strategies_/24889870

المؤلفون: Yaru Guo, Yuanyuan Chen, Yingnan Zhang, Mengjun Xu, Wenwen Guo, Jingya Zhang, Gaolei Ma, Chen Liu, Juan Yang, Xiaojin Wu

مصطلحات موضوعية: Medicine, Biotechnology, Immunology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, transcatheter arterial chemoembolization, recombinant human adenovirus, 67 &# 8211, 65 &# 8211, 28 &# 8211, 13 &# 8211, 09 &# 8211, 02 &# 8211, disease control rate, patients &# 8217, involved 1045 patients, tace markedly improved, meta analysis indicated, clinical curative effects, analysis , 95 &# 8211, 62 &# 8211, 001 ), better survival benefit, +rad%22">xlink "> rad, %22">xlink ">, survival rate

Time: 1

Relation: https://figshare.com/articles/journal_contribution/Forest_plot_of_immune_status_of_patients_in_rAd-p53_combined_with_TACE_group_and_TACE_group_/24889873

الاتاحة: https://doi.org/10.1371/journal.pone.0295323.s002
https://figshare.com/articles/journal_contribution/Forest_plot_of_immune_status_of_patients_in_rAd-p53_combined_with_TACE_group_and_TACE_group_/24889873

المؤلفون: Yaru Guo, Yuanyuan Chen, Yingnan Zhang, Mengjun Xu, Wenwen Guo, Jingya Zhang, Gaolei Ma, Chen Liu, Juan Yang, Xiaojin Wu

مصطلحات موضوعية: Medicine, Biotechnology, Immunology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, transcatheter arterial chemoembolization, recombinant human adenovirus, 67 &# 8211, 65 &# 8211, 28 &# 8211, 13 &# 8211, 09 &# 8211, 02 &# 8211, disease control rate, patients &# 8217, involved 1045 patients, tace markedly improved, meta analysis indicated, clinical curative effects, analysis , 95 &# 8211, 62 &# 8211, 001 ), better survival benefit, +rad%22">xlink "> rad, %22">xlink ">, survival rate

Time: 1

Relation: https://figshare.com/articles/journal_contribution/S3_Fig_-/24889879

الاتاحة: https://doi.org/10.1371/journal.pone.0295323.s004
https://figshare.com/articles/journal_contribution/S3_Fig_-/24889879

المؤلفون: Yaru Guo, Yuanyuan Chen, Yingnan Zhang, Mengjun Xu, Wenwen Guo, Jingya Zhang, Gaolei Ma, Chen Liu, Juan Yang, Xiaojin Wu

مصطلحات موضوعية: Medicine, Biotechnology, Immunology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, transcatheter arterial chemoembolization, recombinant human adenovirus, 67 &# 8211, 65 &# 8211, 28 &# 8211, 13 &# 8211, 09 &# 8211, 02 &# 8211, disease control rate, patients &# 8217, involved 1045 patients, tace markedly improved, meta analysis indicated, clinical curative effects, analysis , 95 &# 8211, 62 &# 8211, 001 ), better survival benefit, +rad%22">xlink "> rad, %22">xlink ">, survival rate

Time: 1

Relation: https://figshare.com/articles/journal_contribution/PRISMA_checklist_/24889882

الاتاحة: https://doi.org/10.1371/journal.pone.0295323.s005
https://figshare.com/articles/journal_contribution/PRISMA_checklist_/24889882